Completed from United Kingdom
The Global Certificate in Pharmacoeconomics (Intermediate) at Stanmore School of Business was exactly what I needed to bridge the gap between theory and practice. The modules on cost‑utility analysis and budget impact modeling gave me the tools to produce robust economic models for my NHS projects. I was particularly impressed by the case‑study workbook that used real‑world UK drug pricing data; it allowed me to apply the techniques immediately and present a cost‑effectiveness report to senior clinicians. The video lectures were concise and the supplementary reading was up‑to‑date with current NICE guidelines. Overall, the course exceeded my learning objectives and I feel fully equipped to lead pharmacoeconomic assessments in my organization.
I took the Intermediate Pharmacoeconomics certificate because I wanted to add some solid economic chops to my pharma consulting gig. The stuff on incremental cost‑effectiveness ratios and sensitivity analysis was spot‑on, and the hands‑on Excel templates helped me build a budget impact model for a new oncology drug in just a few days. The course material felt current—lots of recent US payer perspectives and real‑world evidence examples. The only thing I’d tweak is a bit more interactive discussion, but overall it was a great, practical boost to my skill set.
Wow! This course totally transformed my understanding of pharmacoeconomics. The deep dive into health‑technology assessment frameworks gave me confidence to draft a full HTA submission for a biosimilar in India. I loved the practical exercises—especially the one where we calculated quality‑adjusted life years using local utility values. The lecture slides were crystal clear, and the additional readings on emerging market pricing strategies were incredibly relevant. I’m now able to advise my company on pricing negotiations with a data‑driven approach, and I can’t thank Stanmore enough for such an enthusiastic and empowering learning experience.
The Intermediate level of the Global Certificate in Pharmacoeconomics delivered a detailed and rigorous exploration of economic evaluation methods. Throughout the course, I gained practical skills in constructing decision‑tree models and performing probabilistic sensitivity analyses, which I immediately applied to a cost‑effectiveness study for a malaria vaccine rollout in South Africa. The course materials were comprehensive, featuring up‑to‑date WHO guidelines and region‑specific cost data, which made the learning highly relevant to my work in the public health sector. While the pacing was brisk, the thoroughness of the content and the supportive faculty ensured a satisfying overall experience.
